Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis
Summary Fibroblast growth factor‐19 (FGF‐19) is a gut hormone which interacts with metabolism and is depleted in obesity. There is some indication that the hormone undergoes a resurgence following bariatric surgery (BS), an effect which may contribute to the beneficial outcomes of such procedures. T...
Gespeichert in:
Veröffentlicht in: | Obesity reviews 2020-08, Vol.21 (8), p.e13038-n/a |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 8 |
container_start_page | e13038 |
container_title | Obesity reviews |
container_volume | 21 |
creator | Ryan, Paul M. Hayward, Nathaniel E. Sless, Ryan T. Garwood, Philip Rahmani, Jamal |
description | Summary
Fibroblast growth factor‐19 (FGF‐19) is a gut hormone which interacts with metabolism and is depleted in obesity. There is some indication that the hormone undergoes a resurgence following bariatric surgery (BS), an effect which may contribute to the beneficial outcomes of such procedures. This systematic review and meta‐analysis aims to synthesize the available literature on FGF‐19 levels before and after BS. MEDLINE, Scopus and Web of Science databases were searched, and the effect of different surgical procedures and degrees of body mass index (BMI) reduction on FGF‐19 levels was assessed by DerSimonian and Laird random‐effects model in meta‐analysis and dose–response analyses. This meta‐analysis, which included 474 patients from 25 arms undergoing one of five BS procedures, revealed a significant increase in the levels of circulating FGF‐19 following all‐type BS. Vertical sleeve gastrectomy, duodenal‐jejunal bypass liner and Roux‐en‐Y gastric bypass all significantly increased circulating FGF‐19 levels from baseline. However, gastric banding failed to achieve the same, and in fact, biliopancreatic diversion was associated with decreased circulating FGF‐19. Finally, an inverse association between FGF‐19 and the degree of BMI‐reduction post‐operatively was noted. FGF‐19 is increased by BS and may represent a pharmaceutical target in efforts to reproduce the beneficial effects of BS in a medical setting. |
doi_str_mv | 10.1111/obr.13038 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2394885300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2394885300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-e0edf39fa1f285cfa73d7a4d7fb281e500278280ea9b9df1911feb2f1fd6e22b3</originalsourceid><addsrcrecordid>eNp10MtKxDAUBuAgipfRhS8gATe6GCcnaaeJu1EcFQRBFFwIJU1PJNKLJq3SnY_gM_okRkddCGZzwuHj5_ATsg3sAOKbtIU_AMGEXCLrkEyzcSbV7fLvX8Ia2QjhgTHIlIBVsia44Aqy6Tq5O7EWTUdbSwvtne68MzT0_h79QNuGGudNX-nONfd0fjp_f30DdUhnNAyhwzruDfX47PCF6qakNXY6Et3oaggubJIVq6uAW99zRG7mJ9fHZ-OLy9Pz49nF2IhUyDEyLK1QVoPlMjVWZ6LMdFJmtuASMGWMZ5JLhloVqrSgACwW3IItp8h5IUZkb5H76NunHkOX1y4YrCrdYNuHnAuVSJkKxiLd_UMf2t7He6NKQKVKpUkS1f5CGd-G4NHmj97V2g85sPyz8jxWnn9VHu3Od2Jf1Fj-yp-OI5gswIurcPg_Kb88ulpEfgCieoxD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419599544</pqid></control><display><type>article</type><title>Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ryan, Paul M. ; Hayward, Nathaniel E. ; Sless, Ryan T. ; Garwood, Philip ; Rahmani, Jamal</creator><creatorcontrib>Ryan, Paul M. ; Hayward, Nathaniel E. ; Sless, Ryan T. ; Garwood, Philip ; Rahmani, Jamal</creatorcontrib><description>Summary
Fibroblast growth factor‐19 (FGF‐19) is a gut hormone which interacts with metabolism and is depleted in obesity. There is some indication that the hormone undergoes a resurgence following bariatric surgery (BS), an effect which may contribute to the beneficial outcomes of such procedures. This systematic review and meta‐analysis aims to synthesize the available literature on FGF‐19 levels before and after BS. MEDLINE, Scopus and Web of Science databases were searched, and the effect of different surgical procedures and degrees of body mass index (BMI) reduction on FGF‐19 levels was assessed by DerSimonian and Laird random‐effects model in meta‐analysis and dose–response analyses. This meta‐analysis, which included 474 patients from 25 arms undergoing one of five BS procedures, revealed a significant increase in the levels of circulating FGF‐19 following all‐type BS. Vertical sleeve gastrectomy, duodenal‐jejunal bypass liner and Roux‐en‐Y gastric bypass all significantly increased circulating FGF‐19 levels from baseline. However, gastric banding failed to achieve the same, and in fact, biliopancreatic diversion was associated with decreased circulating FGF‐19. Finally, an inverse association between FGF‐19 and the degree of BMI‐reduction post‐operatively was noted. FGF‐19 is increased by BS and may represent a pharmaceutical target in efforts to reproduce the beneficial effects of BS in a medical setting.</description><identifier>ISSN: 1467-7881</identifier><identifier>EISSN: 1467-789X</identifier><identifier>DOI: 10.1111/obr.13038</identifier><identifier>PMID: 32329176</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>bariatric surgery ; Bariatric Surgery - methods ; bile acids ; Body mass ; Body mass index ; Body size ; FGF‐19 ; Fibroblast growth factors ; Fibroblast Growth Factors - blood ; Gastrectomy ; Gastric bypass ; Gastrointestinal surgery ; Growth factors ; Humans ; Meta-analysis ; Metabolism ; Obesity ; Surgery ; Systematic review</subject><ispartof>Obesity reviews, 2020-08, Vol.21 (8), p.e13038-n/a</ispartof><rights>2020 World Obesity Federation</rights><rights>2020 World Obesity Federation.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-e0edf39fa1f285cfa73d7a4d7fb281e500278280ea9b9df1911feb2f1fd6e22b3</citedby><cites>FETCH-LOGICAL-c3538-e0edf39fa1f285cfa73d7a4d7fb281e500278280ea9b9df1911feb2f1fd6e22b3</cites><orcidid>0000-0002-2007-9241 ; 0000-0001-7251-6725</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fobr.13038$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fobr.13038$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32329176$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ryan, Paul M.</creatorcontrib><creatorcontrib>Hayward, Nathaniel E.</creatorcontrib><creatorcontrib>Sless, Ryan T.</creatorcontrib><creatorcontrib>Garwood, Philip</creatorcontrib><creatorcontrib>Rahmani, Jamal</creatorcontrib><title>Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis</title><title>Obesity reviews</title><addtitle>Obes Rev</addtitle><description>Summary
Fibroblast growth factor‐19 (FGF‐19) is a gut hormone which interacts with metabolism and is depleted in obesity. There is some indication that the hormone undergoes a resurgence following bariatric surgery (BS), an effect which may contribute to the beneficial outcomes of such procedures. This systematic review and meta‐analysis aims to synthesize the available literature on FGF‐19 levels before and after BS. MEDLINE, Scopus and Web of Science databases were searched, and the effect of different surgical procedures and degrees of body mass index (BMI) reduction on FGF‐19 levels was assessed by DerSimonian and Laird random‐effects model in meta‐analysis and dose–response analyses. This meta‐analysis, which included 474 patients from 25 arms undergoing one of five BS procedures, revealed a significant increase in the levels of circulating FGF‐19 following all‐type BS. Vertical sleeve gastrectomy, duodenal‐jejunal bypass liner and Roux‐en‐Y gastric bypass all significantly increased circulating FGF‐19 levels from baseline. However, gastric banding failed to achieve the same, and in fact, biliopancreatic diversion was associated with decreased circulating FGF‐19. Finally, an inverse association between FGF‐19 and the degree of BMI‐reduction post‐operatively was noted. FGF‐19 is increased by BS and may represent a pharmaceutical target in efforts to reproduce the beneficial effects of BS in a medical setting.</description><subject>bariatric surgery</subject><subject>Bariatric Surgery - methods</subject><subject>bile acids</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>FGF‐19</subject><subject>Fibroblast growth factors</subject><subject>Fibroblast Growth Factors - blood</subject><subject>Gastrectomy</subject><subject>Gastric bypass</subject><subject>Gastrointestinal surgery</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Meta-analysis</subject><subject>Metabolism</subject><subject>Obesity</subject><subject>Surgery</subject><subject>Systematic review</subject><issn>1467-7881</issn><issn>1467-789X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKxDAUBuAgipfRhS8gATe6GCcnaaeJu1EcFQRBFFwIJU1PJNKLJq3SnY_gM_okRkddCGZzwuHj5_ATsg3sAOKbtIU_AMGEXCLrkEyzcSbV7fLvX8Ia2QjhgTHIlIBVsia44Aqy6Tq5O7EWTUdbSwvtne68MzT0_h79QNuGGudNX-nONfd0fjp_f30DdUhnNAyhwzruDfX47PCF6qakNXY6Et3oaggubJIVq6uAW99zRG7mJ9fHZ-OLy9Pz49nF2IhUyDEyLK1QVoPlMjVWZ6LMdFJmtuASMGWMZ5JLhloVqrSgACwW3IItp8h5IUZkb5H76NunHkOX1y4YrCrdYNuHnAuVSJkKxiLd_UMf2t7He6NKQKVKpUkS1f5CGd-G4NHmj97V2g85sPyz8jxWnn9VHu3Od2Jf1Fj-yp-OI5gswIurcPg_Kb88ulpEfgCieoxD</recordid><startdate>202008</startdate><enddate>202008</enddate><creator>Ryan, Paul M.</creator><creator>Hayward, Nathaniel E.</creator><creator>Sless, Ryan T.</creator><creator>Garwood, Philip</creator><creator>Rahmani, Jamal</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2007-9241</orcidid><orcidid>https://orcid.org/0000-0001-7251-6725</orcidid></search><sort><creationdate>202008</creationdate><title>Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis</title><author>Ryan, Paul M. ; Hayward, Nathaniel E. ; Sless, Ryan T. ; Garwood, Philip ; Rahmani, Jamal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-e0edf39fa1f285cfa73d7a4d7fb281e500278280ea9b9df1911feb2f1fd6e22b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>bariatric surgery</topic><topic>Bariatric Surgery - methods</topic><topic>bile acids</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>FGF‐19</topic><topic>Fibroblast growth factors</topic><topic>Fibroblast Growth Factors - blood</topic><topic>Gastrectomy</topic><topic>Gastric bypass</topic><topic>Gastrointestinal surgery</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Meta-analysis</topic><topic>Metabolism</topic><topic>Obesity</topic><topic>Surgery</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ryan, Paul M.</creatorcontrib><creatorcontrib>Hayward, Nathaniel E.</creatorcontrib><creatorcontrib>Sless, Ryan T.</creatorcontrib><creatorcontrib>Garwood, Philip</creatorcontrib><creatorcontrib>Rahmani, Jamal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ryan, Paul M.</au><au>Hayward, Nathaniel E.</au><au>Sless, Ryan T.</au><au>Garwood, Philip</au><au>Rahmani, Jamal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis</atitle><jtitle>Obesity reviews</jtitle><addtitle>Obes Rev</addtitle><date>2020-08</date><risdate>2020</risdate><volume>21</volume><issue>8</issue><spage>e13038</spage><epage>n/a</epage><pages>e13038-n/a</pages><issn>1467-7881</issn><eissn>1467-789X</eissn><abstract>Summary
Fibroblast growth factor‐19 (FGF‐19) is a gut hormone which interacts with metabolism and is depleted in obesity. There is some indication that the hormone undergoes a resurgence following bariatric surgery (BS), an effect which may contribute to the beneficial outcomes of such procedures. This systematic review and meta‐analysis aims to synthesize the available literature on FGF‐19 levels before and after BS. MEDLINE, Scopus and Web of Science databases were searched, and the effect of different surgical procedures and degrees of body mass index (BMI) reduction on FGF‐19 levels was assessed by DerSimonian and Laird random‐effects model in meta‐analysis and dose–response analyses. This meta‐analysis, which included 474 patients from 25 arms undergoing one of five BS procedures, revealed a significant increase in the levels of circulating FGF‐19 following all‐type BS. Vertical sleeve gastrectomy, duodenal‐jejunal bypass liner and Roux‐en‐Y gastric bypass all significantly increased circulating FGF‐19 levels from baseline. However, gastric banding failed to achieve the same, and in fact, biliopancreatic diversion was associated with decreased circulating FGF‐19. Finally, an inverse association between FGF‐19 and the degree of BMI‐reduction post‐operatively was noted. FGF‐19 is increased by BS and may represent a pharmaceutical target in efforts to reproduce the beneficial effects of BS in a medical setting.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32329176</pmid><doi>10.1111/obr.13038</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2007-9241</orcidid><orcidid>https://orcid.org/0000-0001-7251-6725</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1467-7881 |
ispartof | Obesity reviews, 2020-08, Vol.21 (8), p.e13038-n/a |
issn | 1467-7881 1467-789X |
language | eng |
recordid | cdi_proquest_miscellaneous_2394885300 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | bariatric surgery Bariatric Surgery - methods bile acids Body mass Body mass index Body size FGF‐19 Fibroblast growth factors Fibroblast Growth Factors - blood Gastrectomy Gastric bypass Gastrointestinal surgery Growth factors Humans Meta-analysis Metabolism Obesity Surgery Systematic review |
title | Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T19%3A25%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20bariatric%20surgery%20on%20circulating%20FGF%E2%80%9019:%20A%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=Obesity%20reviews&rft.au=Ryan,%20Paul%20M.&rft.date=2020-08&rft.volume=21&rft.issue=8&rft.spage=e13038&rft.epage=n/a&rft.pages=e13038-n/a&rft.issn=1467-7881&rft.eissn=1467-789X&rft_id=info:doi/10.1111/obr.13038&rft_dat=%3Cproquest_cross%3E2394885300%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419599544&rft_id=info:pmid/32329176&rfr_iscdi=true |